Reinterventions and sac dynamics after fenestrated endovascular aortic repair with physician-modified endografts for index aneurysm repair and following proximal failure of prior endovascular aortic repair

医学 腔内修复术 外科 动脉瘤 主动脉瘤 主动脉修补术 放射科 腹主动脉瘤
作者
Andrew P. Sanders,Nicholas J. Swerdlow,Sai Divya Yadavalli,Christina L. Marcaccio,Lars Stangenberg,Marc L. Schermerhorn
出处
期刊:Journal of Vascular Surgery [Elsevier BV]
卷期号:79 (6): 1287-1294.e1 被引量:6
标识
DOI:10.1016/j.jvs.2024.01.002
摘要

Abstract

Objective

The high frequency of reinterventions after fenestrated endovascular aortic repair (FEVAR) with physician-modified endografts (PMEGs) has been well-studied. However, the impact of prior EVAR on reinterventions and sac behavior following these procedures remains unknown. We analyzed 3-year rates of reinterventions and sac dynamics following PMEG for index aneurysm repair compared with PMEG for prior EVAR with loss of proximal seal.

Methods

We performed a retrospective analysis of 122 consecutive FEVARs with PMEGs at a tertiary care center submitted to the United States Food and Drug Administration in support of an investigational device exemption trial. We excluded patients with aortic dissection (n = 5), type I to III thoracoabdominal aneurysms (n = 13), non-elective procedures (n = 4), and prior aortic surgery other than EVAR (n = 8), for a final cohort of 92 patients. Patients were divided into those who underwent PMEG for index aneurysm repair (primary FEVAR) and those who underwent PMEG for rescue of prior EVAR with loss of proximal seal (secondary FEVAR). The primary outcomes were freedom from reintervention and sac dynamics (regression as ≥5 mm decrease, expansion as ≥5 mm increase, and stability as <5 mm increase or decrease) at 3 years. Secondary outcomes were perioperative mortality and 3-year survival.

Results

Of the 92 patients included, 56 (61%) underwent primary FEVAR and 36 (39%) underwent secondary FEVAR. Secondary FEVAR patients were older (78 years [interquartile range (IQR), 74.5-83.5 years] vs 73 years [IQR, 69-78.5 years]; P < .001), more frequently male (86% vs 68%; P = .048), and had larger aneurysms (72.5 mm [IQR, 65.5-81 mm] vs 59 mm [IQR, 55-65 mm]; P < .001). Perioperative mortality was 1.8% for primary FEVAR and 2.7% for secondary FEVAR (P = .75). At 3 years, overall survival was 84% for primary FEVAR and 71% for secondary FEVAR (P = .086). Freedom-from reintervention was significantly higher for primary FEVAR than secondary FEVAR, specifically 82% vs 38% at 3 years (P < .001). Primary FEVAR also had more desirable sac dynamics relative to secondary FEVAR at 3 years (primary: 54% stable, 46% regressed, 0% expanded vs secondary: 33% stable, 28% regressed, and 39% expanded; P = .038).

Conclusions

FEVAR for primary aortic repair and FEVAR for rescue of prior EVAR with loss of proximal seal are two distinct entities. Following primary FEVAR, less than a quarter of patients have undergone reintervention at 3 years, and sac expansion was not seen in our cohort. Comparatively, 3 years after secondary FEVAR, over one-half of patients have undergone reintervention and over one-third have had ongoing sac expansion. Vigilant surveillance and a low threshold for further interventions are crucial following secondary FEVAR.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
辛勤冰绿完成签到,获得积分10
刚刚
XZY完成签到,获得积分10
刚刚
李爱国应助小田儿采纳,获得10
刚刚
watermelon完成签到,获得积分10
1秒前
小李的李完成签到,获得积分10
2秒前
fangruofuyun完成签到,获得积分10
2秒前
科目三应助无奈的书琴采纳,获得10
2秒前
老唐老唐完成签到 ,获得积分10
4秒前
自觉的丹珍完成签到,获得积分10
4秒前
闪闪的金鱼完成签到 ,获得积分10
5秒前
5秒前
6秒前
大模型应助草莓大果汁采纳,获得10
7秒前
hjc完成签到 ,获得积分10
8秒前
科研通AI6.2应助Mortisssssssss采纳,获得10
8秒前
李明月完成签到,获得积分10
9秒前
123完成签到,获得积分10
9秒前
开朗的千雁完成签到 ,获得积分10
9秒前
10秒前
稳重墨镜发布了新的文献求助10
11秒前
12秒前
追寻澜完成签到 ,获得积分10
12秒前
Sxq完成签到,获得积分10
12秒前
13秒前
李爱国应助康康采纳,获得10
13秒前
hotmail发布了新的文献求助10
14秒前
小田儿发布了新的文献求助10
15秒前
17秒前
17秒前
爆米花应助lllkate采纳,获得10
18秒前
彭于晏应助Clara6208采纳,获得10
19秒前
Smithjiang发布了新的文献求助10
21秒前
21秒前
21秒前
gwfew发布了新的文献求助10
22秒前
何必在乎发布了新的文献求助10
26秒前
不喝蒙牛发布了新的文献求助10
27秒前
空白完成签到 ,获得积分10
28秒前
空空完成签到,获得积分10
28秒前
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6015269
求助须知:如何正确求助?哪些是违规求助? 7591856
关于积分的说明 16148330
捐赠科研通 5162928
什么是DOI,文献DOI怎么找? 2764236
邀请新用户注册赠送积分活动 1744789
关于科研通互助平台的介绍 1634673